What’s new

• The filing is a transcript of the May 25, 2026, earnings call.
• It covers audited results for Q4 and full-year FY26.
• The document contains no information beyond what was already summarized in the earlier concall filing.

Why it matters

Investors looking for incremental detail on the company's UK concentration or its downward guidance revision will not find it here. The transcript is a routine record of a call that has already been digested by the market.

What we’re watching

• Execution on the stated diversification plans.
• Updates on the UK market concentration risk.
• Future guidance revisions.

The full read

Crizac has filed the transcript of its earnings call from May 25, 2026. The document covers the audited results for Q4 and the full year of FY26.

It adds nothing.

Investors seeking new insights into the company's downward guidance revision or its heavy reliance on the UK market will find no additional information here, as the transcript simply repeats the management commentary already provided in the earlier concall summary, making this a routine procedural filing that fails to move the needle for any serious analyst.

Primary source: BSE · NSE

What’s new

• Crizac cut its full-year revenue growth target to 15-17%, from an earlier range of 25-30%.
• UK revenue concentration rose to 97%, contradicting management's prior statements of a decline.
• Management set a target to reduce UK exposure to below 60% by FY28 through new markets and acquisitions.

Why it matters

A cut to growth guidance from 25-30% down to 15-17% is a major shift. The revelation that UK revenue is 97% of the business, when management had claimed it was below 90%, is a credibility problem. The new diversification plan is an attempt to fix a risk that was publicly denied.

What we’re watching

• Execution of the four acquisition targets in FY26.
• Any early revenue traction from Australia, New Zealand, or North America.
• Whether the stock re-rates on the concentration risk or the acquisition-driven growth plan.

The full read

Crizac's fiscal year ended with solid numbers: revenue of ₹10,422 million, up 22.7%, and net profit of ₹2,191 million, up 41%. The concall rewrote the forward story. Management cut its full-year growth outlook to 15-17% from a prior range of 25-30%, citing geopolitical uncertainty. More damaging was the disclosure that UK revenue is 97% of its destination business, not below the 90% management had previously suggested. The company now plans to reduce UK exposure to below 60% by FY28 through four acquisitions in fiscal 2026 and expansion into Australia, New Zealand, and North America. The disconnect between the prior diversification narrative and today's 97% figure is the core issue. Crizac is now pitching a multi-year remediation plan for a risk it had told investors was already contained.

Primary source: BSE · NSE